Healthcare Headlines from the Hill: November Edition

Stay ahead of the latest regulatory shifts and healthcare breaking news with Headlines from the Hill.
In this month’s edition you will find:
- IRF Review Choice selection period now open for Alabama, Tennessee and Georgia.
- 2027 healthcare policy outlook: Key priorities for the 120th congress.
- Post-acute care: The Federation of American Hospitals responds to MedPAC utilization analysis.
IRF Review Choice selection period now open for Alabama, Tennessee and Georgia.
The Cycle 1 Review Choice Demonstration (RCD) selection period for inpatient rehabilitation facilities (IRFs) billing to Medicare Jurisdiction J (Alabama, Tennessee and Georgia) opened November 13 and closes December 14.
Participating IRFs must select either 100% pre-claim review or 100% post-payment review. Facilities that do not make a selection will automatically be assigned to post-payment review. The first review cycle runs from January 1 through June 30, 2027.
IRFs should review their options and submit their selection before the December 14 deadline.
2027 healthcare policy outlook: Key priorities for the 120th congress.
As the 120th Congress convenes, healthcare affordability, coverage stability and regulatory oversight are expected to top the legislative agenda. While congressional Democrats aim to revisit major provisions of the 2025 One Big Beautiful Bill Act (OBBBA), a divided government means sweeping legislative reversals will likely face presidential veto hurdles. For healthcare executives, the most immediate operational impacts will stem from appropriations negotiations, targeted bipartisan compromises and heightened committee oversight.
Early proposals will likely focus on delaying or modifying OBBBA provisions – specifically Medicaid work requirements, six-month eligibility redeterminations and limits on provider taxes and state-directed payments (SDPs). Lawmakers are also expected to push for restoring the enhanced Affordable Care Act (ACA) Advanced Premium Tax Credits (eAPTCs) that expired at the end of 2025.
Regulatory and industry oversight
With direct legislative paths constrained, congressional committees are expected to rely heavily on oversight of federal agencies to influence policy implementation. Healthcare leaders should prepare for increased scrutiny across two fronts:
- Agency execution: Monitoring how the administration implements OBBBA rules, alongside agency decisions on Medicare Advantage (MA), vaccine policy, biomedical research funding and reproductive health.
- Market practices: Ongoing bipartisan interest in hospital and insurer price transparency, pharmacy benefit manager (PBM) practices, the 340B Drug Pricing Program, prior authorization, vertical integration and private equity investment in healthcare.
Rural healthcare outlook
Supporting rural hospitals, protecting Medicaid funding and expanding telehealth remain stated priorities, alongside investments in rural workforce development. However, securing sustained legislative momentum may prove challenging. Because Democrats' electoral base is concentrated largely in urban and suburban districts, rural health initiatives risk being folded into broader affordability debates rather than advancing as standalone priorities. This will require health systems to actively demonstrate the localized economic and clinical impacts of federal funding shifts.
Post-acute care: The Federation of American Hospitals responds to MedPAC utilization analysis.
The Federation of American Hospitals (FAH) recently submitted comments to the Medicare Payment Advisory Commission (MedPAC) regarding its September analysis comparing post-acute care utilization between traditional fee-for-service (FFS) Medicare and Medicare Advantage (MA).
While MedPAC found that MA beneficiaries utilize less post-acute care across all settings, most notably in inpatient rehabilitation facilities (IRFs), FAH urged the Commission not to interpret lower utilization as inherent care efficiency. Instead, FAH highlighted potential discharge bottlenecks and coverage barriers, pointing to MedPAC data showing that MA patients bound for an IRF experience 32 percent longer acute hospital stays, alongside Office of Inspector General (OIG) findings that MA plans overturned 43 percent of appealed IRF denials and 36 percent of appealed long-term care hospital (LTCH) denials.
To ensure future analyses reflect the full episode of care, FAH recommended that MedPAC:
- Combine acute and post-acute days when evaluating length of stay to capture downstream discharge delays.
- Supplement claims data with direct input from hospital case managers and discharge planners.
- Focus additional scrutiny on utilization and access trends within IRFs and LTCHs.
Why is this important? As federal advisors scrutinize total episode length and MA utilization, discharge bottlenecks directly impact hospital capacity and reimbursement. Partnering with a trusted, experienced post-acute provider helps hospitals navigate complex prior authorization barriers, streamline transitions of care and reduce costly acute-care delays.
Contact us today to learn how Lifepoint Rehabilitation can help your hospital navigate regulatory complexities and stay ahead of future shifts.
Get in touch
Contact us today to learn how partnership with Lifepoint could benefit your hospital and community.